A novel NIR-II probe for improved tumor-targeting NIR-II imaging.

Hu, Chao; Guo, Tengyu; Li, Huizhou; Xu, Pengfei; Xiao, Yudong

Hu, Chao; Guo, Tengyu; Li, Huizhou; Xu, Pengfei; Xiao, Yudong.

Afiliación

Hu C; Department of Radiology, The Second Xiangya Hospital, Central South University Changsha Hunan 410011 P. R. China xiaoyudong222@csu.edu.cn.
Guo T; College of Chemistry Jilin University Changchun 130012 P. R. China.
Li H; Department of Radiology, The Second Xiangya Hospital, Central South University Changsha Hunan 410011 P. R. China xiaoyudong222@csu.edu.cn.
Xu P; Institute of Clinical Pharmacy & Pharmacology, Jining First People's Hospital, Jining Medical University Jining 272000 P. R. China pengfeixucsu@outlook.com.
Xiao Y; Department of Radiology, The Second Xiangya Hospital, Central South University Changsha Hunan 410011 P. R. China xiaoyudong222@csu.edu.cn.

RSC Adv ; 11(62): 39287-39290, 2021 Dec 06.

Article en En | MEDLINE | ID: mdl-35492481

ABSTRACT

ABSTRACT

In this work, we report a novel probe IR-RGD, which possesses a bright emission tail in the NIR-II region along with high quantum yield. Further, IR-RGD has been successfully used for tumor-targeting NIR-II fluorescence imaging with great potential for clinical translation.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: RSC Adv Año: 2021 Tipo del documento: Article